Posts

The Financial World: ZIM Laboratories Limited Listing on BSE Main Board

ZIM Laboratories Limited (ZIM) has been listed on the BSE Main Board on June 8, 2018. The book value price of ZIM was Rs 160 per equity share. Anwar Daud, Chairman & Managing Director, told media persons here recently that ZIM is amongst the few global companies to have developed and commercialized the oral film technology, besides also being the first Indian company to manufacture multi-layer thin films that contain more than one API on a single thin strip. Describing ZIM Laboratories as a unique R&D-centered pharmaceutical company focused on developing and supply of complex generics products based on proprietary Novel Drug Delivery Solutions (NDDS), he said ZIM got listed on OTC Exchange of India in 1994, following the SEBI guidelines and the company listing on BSE on June 8 had a price discovery as per trading on the bourses. Original Article
Post a Comment
Read more

APN News: ZIM Laboratories Limited to List on BSE Main Board on June 8, 2018

ZIM Laboratories Limited (ZIM) – is a unique R&D centered pharmaceutical company focused on developing and supply of complex generics products based on proprietary  Novel Drug Delivery Solutions (NDDS). Promoted by Technocrat Dr. Anwar Daud, the company has a Unique R&D focused business model helping customers with product development, co-development, out licensing, manufacturing, supplies and marketing support with a strong IP base – 26 inventions with 53 patent filings and 174 clients across 45 countries. Original Article  
Post a Comment
Read more

Global Prime News: ZIM Laboratories Limited to List on BSE Main Board on June 8, 2018

ZIM is amongst a few companies globally to have developed and commercialized the oral film technology. The first Indian company to manufacture multi-layer thin films - that contain more than one API on a single thin strip. Company to get listed on BSE Mainboard on June 08, 2018. The book value price of ZIM is Rs.160/- per equity share. ZIM got listed on OTC Exchange on India in 1994, following the SEBI guidelines the company will be listing on BSE and will have a price discovery as per trading on the bourses. ZIM Laboratories Limited (ZIM) – is a unique R&D centered pharmaceutical company focused on developing and supply of complex generics products based on proprietary Novel Drug Delivery Solutions (NDDS). Original Article  
Post a Comment
Read more

NRI News 24x7: ZIM Laboratories Limited to List on BSE Main Board on June 8, 2018

ZIM is amongst a few companies globally to have developed and commercialized the oral film technology. The first Indian company to manufacture multi-layer thin films – that contain more than one API on a single thin strip. Company to get listed on BSE Mainboard on June 08, 2018 . The book value price of ZIM is Rs. 160/-  per equity share ZIM Laboratories Limited (ZIM) – is a unique R&D centered pharmaceutical company focused on developing and supply of complex generics products based on proprietary  Novel Drug Delivery Solutions (NDDS). ZIM got listed on OTC Exchange of India in 1994, following the SEBI guidelines the company will be listing on BSE and will have a price discovery as per trading on the bourses. Original Article
Post a Comment
Read more

Malayalam Daily Press: Zim Laboratories to be listed on BSE tomorrow

Nagpur-based pharmaceuticals company Zim Laboratories will list on BSE on Friday, June 8. Zim Labs was trading on the OTC Exchange Of India before the Securities Exchange Board of India (SEBI) withdrew its recognition of it in March 2015. The company was recently by allowed SEBI to list on the main board of BSE.  This listing will provide an exit to some of its existing shareholders. The book value of Zim Labs, promoted by Anwar Daud, is Rs 160 per equity share. Daud and his family own 54 percent stake in the company, and private equity firm Ashmore Alchemy India Advisors owns around 22 percent. The rest is owned by minority shareholders. Original Article  
Post a Comment
Read more

India Med Today: ZIM Laboratories Limited to List on BSE Main Board on June 8, 2018

ZIM Laboratories Limited (ZIM) – is a unique R&D centered pharmaceutical company focused on developing and supply of complex generics products based on proprietary  Novel Drug Delivery Solutions (NDDS). ZIM got listed on OTC Exchange of India in 1994, following the SEBI guidelines the company will be listing on BSE and will have a price discovery as per trading on the bourses. Promoted by Technocrat Dr. Anwar Daud, the company has a Unique R&D focused business model helping customers with product development, co-development, out licensing, manufacturing, supplies and marketing support with a strong IP base – 26 inventions with 53 patent filings and 174 clients across 45 countries. Original Article  
Post a Comment
Read more

State Times: ZIM Laboratories Ltd to List on BSE on Friday

ZIM Laboratories (ZIM), an R&D centred pharmaceutical company today said it will list its shares on BSE on Friday. ZIM got listed on OTC Exchange of India in 1994, following the Sebi guidelines the company will be listing on BSE and will have a price discovery as per trading on the bourses. The book value price is Rs 160 per equity share. Original Article
Post a Comment
Read more